57 results on '"Yang, Han‐Mo"'
Search Results
2. The Impact of Transcatheter Aortic Valve Implantation on Health Care Costs and Clinical Outcomes Based on Frailty Risk: A Nationwide Cohort Analysis
3. Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin in Patients with Dyslipidemia and Hypertension: A Multicenter Randomized Clinical Trial
4. Impact of Age on Antiplatelet Monotherapy in the Chronic Maintenance Period After Percutaneous Coronary Intervention: A Post Hoc Analysis From the HOST-EXAM Extended Study
5. Comparison of Antiplatelet Monotherapies After Percutaneous Coronary Intervention According to Clinical, Ischemic, and Bleeding Risks
6. Prasugrel-Based De-Escalation in Patients With Acute Coronary Syndrome According to Renal Function
7. Resistin impairs mitochondrial homeostasis via cyclase-associated protein 1-mediated fission, leading to obesity-induced metabolic diseases
8. Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions
9. Benefit of Extended Dual Antiplatelet Therapy Duration in Acute Coronary Syndrome Patients Treated with Drug Eluting Stents for Coronary Bifurcation Lesions (from the BIFURCAT Registry)
10. Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
11. Dual Antiplatelet Therapy Duration Determines Outcome After 2- But Not 1-Stent Strategy in Left Main Bifurcation Percutaneous Coronary Intervention
12. Impact of Optimized Procedure-Related Factors in Drug-Eluting Balloon Angioplasty for Treatment of In-Stent Restenosis
13. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry
14. Usefulness of the Baseline Syntax Score to Predict 3-Year Outcome After Complete Revascularization by Percutaneous Coronary Intervention
15. Comparison Among Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for the Treatment of In-Stent Restenosis: A Network Meta-Analysis of 11 Randomized, Controlled Trials
16. Clopidogrel vs Aspirin in the Chronic Maintenance Period for Patients With Acute Coronary Syndrome
17. Three-Year Patient-Related and Stent-Related Outcomes of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice (from the Multicenter Prospective EXCELLENT and RESOLUTE-Korea Registries)
18. Adenylyl Cyclase-Associated Protein 1 Is a Receptor for Human Resistin and Mediates Inflammatory Actions of Human Monocytes
19. A Novel Noninvasive Technology for Treatment Planning Using Virtual Coronary Stenting and Computed Tomography-Derived Computed Fractional Flow Reserve
20. Adjunctive Cilostazol Versus Double-Dose Clopidogrel After Drug-Eluting Stent Implantation: The HOST-ASSURE Randomized Trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis–Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen)
21. Clinical and Physiological Outcomes of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Serial Stenoses Within One Coronary Artery
22. The Recanalization of Chronic Total Occlusion Leads to Lumen Area Increase in Distal Reference Segments in Selected Patients: An Intravascular Ultrasound Study
23. Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies
24. Relationship Between Fractional Flow Reserve and Angiographic and Intravascular Ultrasound Parameters in Ostial Lesions: Major Epicardial Vessel Versus Side Branch Ostial Lesions
25. SHORT-TERM DUAL ANTIPLATELET THERAPY REDUCES BLEEDING RISK WITHOUT INCREASING ISCHEMIC RISK IN PATIENTS UNDERGOING COMPLEX PERCUTANEOUS CORONARY INTERVENTION WITH THIRD-GENERATION DRUG-ELUTING STENTS: A POST HOC ANALYSIS OF THE HOST-IDEA TRIAL
26. Everolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: The EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) Randomized Trial
27. Paclitaxel- Versus Sirolimus-Eluting Stents for Treatment of ST-Segment Elevation Myocardial Infarction: With Analyses for Diabetic and Nondiabetic Subpopulation
28. TCT-380 The Impact of Obesity on Antiplatelet Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Substudy of the HOST-EXAM Trial
29. TCT-372 Hemodynamic Performance of the Intra-Annular and the Supra-Annular Aortic Valves for Transcatheter Aortic Valve Replacement
30. A New Hemodynamic Index Predicting Paravalvular Regurgitation After TAVR: Dicrotic AR Index
31. Safety and Efficacy of Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Myocardial Infarction in the Presence of Intracoronary Thrombus: An Analysis From the Grand Drug-eluting Stent Registry
32. DURABLE POLYMER AND BIODEGRADABLE POLYMER DRUG-ELUTING STENTS AFTER COMPLEX CORONARY INTERVENTION IN ACUTE CORONARY SYNDROME: A POST HOC ANALYSIS FROM THE HOST-REDUCE-POLYTECH-ACS TRIAL
33. TCT-8 Prasugrel De-Escalation Therapy After Complex Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Subgroup Analysis of the HOST-REDUCE-POLYTECH-ACS Randomized Clinical Trial
34. TCT-6 Impact of Diabetes Mellitus on the Effectiveness of Aspirin Versus Clopidogrel as a Chronic Maintenance Antiplatelet Monotherapy After Percutaneous Coronary Intervention: Results From the HOST-EXAM Trial
35. TCTAP A-051 Angiographic Complete Revascularization Versus Incomplete Revascularization in Patients with Diabetes Mellitus
36. TCTAP A-002 Limitation of Angiographic Parameters in Predicting Residual Ischemia After Drug-eluting Stent Implantation
37. TCT-727 Relevance of type and dose of beta-blockers in prognosis among patients with ischemic heart disease: Data from GRAND-DES Registry
38. TCT-679 The impact of complete revascularization in STEMI patients with left ventricular dysfunction
39. TCT-580 Relationship between adverse plaque characteristics and wall shear stress assessed by computational fluid dynamics
40. TCT-412 Side Branch Intervention for Non-Left Main True Bifurcation Lesions: Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort
41. TCT-754 One-year clinical outcome of patients treated with Resolute Onyx versus Resolute Integrity: A Comparison of the HOST-ONYX and HOST-RESOLINTE Registries
42. TCT-753 Long-Term Comparison of Platinum Chromium Everolimus-Eluting and Cobalt Chromium Zotarolimus-Eluting Stents: Three-Year Outcome of the HOST-ASSURE Randomized Trial
43. TCT-415 The influence of sex on fractional flow reserve is different by lesion location
44. TCT-413 Clinical Relevance of Adverse Plaque and Hemodynamic Characteristics in Non-obstructive Lesions in the Prediction of Risk for Acute Coronary Syndrome
45. TCT-218 The ‘SYNTAX Score derivatives’ to predict clinical outcomes after percutaneous coronary intervention with Everolimus-eluting stents for Left main/three vessel disease patients
46. TCT-29 Mechanism of Low Fractional Flow Reserve in Lesions without angiographic significant stenosis: Role of hidden Plaque Burden
47. TCTAP A-135 Physiological Characteristics of Discordance Between Fractional Flow Reserve and Instantaneous Wave-Free Ratio
48. BASELINE SYNTAX SCORE PREDICTS CLINICAL OUTCOME AFTER COMPLETE REVASCULARIZATION IN PATIENTS WITH MULTIVESSEL DISEASE
49. THE CLINICAL SYNTAX SCORE IS SUPERIOR TO THE SYNTAX SCORE IN HIGH-RISK PATIENTS
50. REAL-WORLD EXPERIENCE OF BIOLIMUS A9-ELUTING STENTS AND COMPARISON WITH EVEROLIMUS-ELUTING XIENCE PRIME STENTS IN ALL-COMER REGISTRIES: PRELIMINARY REPORT FOR PATIENT-ORIENTED AND STENT-RELATED 2-YEAR OUTCOMES FROM THE MULTICENTER PROSPECTIVE BIOLIMUS-KOREA-3000 REGISTRY AND EXCELLENT-PRIME REGISTRY
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.